Recent advances in managing gastrointestinal stromal tumor

Por Duffaud, Florence, Le Cesne, Axel
Publicado no F1000Res (2017)

Optimizing Tyrosine Kinase Inhibitor Therapy in Gastrointestinal Stromal Tumors: Exploring the Benefits of Continuous Kinase Suppression

Por Le Cesne, Axel, Blay, Jean-Yves, Reichardt, Peter, Joensuu, Heikki
Publicado em 2013

Survival of soft tissue sarcoma patients after completing six cycles of first-line anthracycline containing treatment: an EORTC-STBSG database study

Por Verschoor, Arie Jan, Litière, Saskia, Marréaud, Sandrine, Judson, Ian, Toulmonde, Maud, Wardelmann, Eva, LeCesne, Axel, Gelderblom, Hans
Publicado no Clin Sarcoma Res (2020)

PARP1 expression in soft tissue sarcomas is a poor‐prognosis factor and a new potential therapeutic target

Por Bertucci, François, Finetti, Pascal, Monneur, Audrey, Perrot, Delphine, Chevreau, Christine, Le Cesne, Axel, Blay, Jean‐Yves, Mir, Olivier, Birnbaum, Daniel
Publicado no Mol Oncol (2019)

Outcome of Patients with Soft‐Tissue Sarcomas: An Age‐Specific Conditional Survival Analysis

Por Bourcier, Kevin, Dinart, Derek, Le Cesne, Axel, Honoré, Charles, Meeus, Pierre, Blay, Jean‐Yves, Michot, Audrey, Le Loarer, François, Italiano, Antoine
Publicado no Oncologist (2019)

PDL1 expression is a poor-prognosis factor in soft-tissue sarcomas

Por Bertucci, François, Finetti, Pascal, Perrot, Delphine, Leroux, Agnès, Collin, Françoise, Le Cesne, Axel, Coindre, Jean-Michel, Blay, Jean-Yves, Birnbaum, Daniel, Mamessier, Emilie
Publicado no Oncoimmunology (2017)

Study protocol of REGOSARC trial: activity and safety of regorafenib in advanced soft tissue sarcoma: a multinational, randomized, placebo-controlled, phase II trial

Por Brodowicz, Thomas, Liegl-Atzwager, Bernadette, Tresch, Emmanuelle, Taieb, Sophie, Kramar, Andrew, Gruenwald, Viktor, Vanseymortier, Marie, Clisant, Stéphanie, Blay, Jean-Yves, Le Cesne, Axel, Penel, Nicolas
Publicado no BMC Cancer (2015)

Outcomes of Elderly Patients with Advanced Soft Tissue Sarcoma Treated with First‐Line Chemotherapy: A Pooled Analysis of 12 EORTC Soft Tissue and Bone Sarcoma Group Trials

Por Younger, Eugenie, Litière, Saskia, Le Cesne, Axel, Mir, Olivier, Gelderblom, Hans, Italiano, Antoine, Marreaud, Sandrine, Jones, Robin Lewis, Gronchi, Alessandro, van der Graaf, Winette T.A.
Publicado no Oncologist (2018)

Assessing Prognostic and Predictive Biomarkers of Regorafenib Response in Patients with Advanced Soft Tissue Sarcoma: REGOSARC Study

Por Brodowicz, Thomas, Liegl-Atzwanger, Bernadette, Penel, Nicolas, Mir, Olivier, Blay, Jean-Yves, Kashofer, Karl, Le Cesne, Axel, Decoupigny, Emilie, Wallet, Jennifer, Hamacher, Rainer, Le Deley, Marie-Cecile
Publicado no Cancers (Basel) (2020)

Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial

Por Cupissol Didier, Rios Maria, Adenis Antoine, Bui Binh, Ray-Coquard Isabelle, Fayette Jerome, Bertucci François, Cassier Philippe A, Blesius Aurore, Pérol David, Blay Jean-Yves, Le Cesne Axel
Publicado em 2011-02-01

Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial

Por Blesius, Aurore, Cassier, Philippe A, Bertucci, François, Fayette, Jerome, Ray-Coquard, Isabelle, Bui, Binh, Adenis, Antoine, Rios, Maria, Cupissol, Didier, Pérol, David, Blay, Jean-Yves, Le Cesne, Axel
Publicado em 2011

Recombinant erythropoietin for the anaemia of patients with advanced Gastrointestinal Stromal Tumours (GIST) receiving imatinib: an active agent only in non progressive patients

Por Duffaud, Florence, Even, Caroline, Ray-Coquard, Isabelle, Bompas, Emmanuelle, Khoa-Huynh, Thanh, Salas, Sebastien, Cassier, Philippe, Dufresne, Armelle, Bonvalot, Sylvie, Ducimetiere, Francoise, Le Cesne, Axel, Blay, Jean-Yves
Publicado em 2012

Trabectedin in advanced synovial sarcomas: a multicenter retrospective study from four European institutions and the Italian Rare Cancer Network

Por Sanfilippo, Roberta, Dileo, Palma, Blay, Jean-Yves, Constantinidou, Anastasia, Le Cesne, Axel, Benson, Charlotte, Vizzini, Laura, Contu, Marianna, Baldi, Giacomo G., Dei Tos, Angelo P., Casali, Paolo G.
Publicado no Anticancer Drugs (2015)

Antiangiogenic effects in patients with progressive desmoplastic small round cell tumor: data from the French national registry dedicated to the use of off-labeled targeted therapy...

Por Bétrian, Sarah, Bergeron, Christophe, Blay, Jean-Yves, Bompas, Emmanuelle, Cassier, Philippe A., Chevallier, Laure, Fayette, Jérome, Girodet, Magali, Guillemet, Cécile, Le Cesne, Axel, Marec-Berard, Perrine, Ray-Coquard, Isabelle, Chevreau, Christine
Publicado no Clin Sarcoma Res (2017)

Phase I clinical trial combining imatinib mesylate and IL-2 in refractory cancer patients: IL-2 interferes with the pharmacokinetics of imatinib mesylate

Por Pautier, Patricia, Locher, Clara, Robert, Caroline, Deroussent, Alain, Flament, Caroline, Le Cesne, Axel, Rey, Annie, Bahleda, Ratislav, Ribrag, Vincent, Soria, Jean-Charles, Vassal, Gilles, Eggermont, Alexander, Zitvogel, Laurence, Chaput, Nathalie, Paci, Angelo
Publicado em 2013

Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas: A Phase 2 Clinical Trial

Por Toulmonde, Maud, Penel, Nicolas, Adam, Julien, Chevreau, Christine, Blay, Jean-Yves, Le Cesne, Axel, Bompas, Emmanuelle, Piperno-Neumann, Sophie, Cousin, Sophie, Grellety, Thomas, Ryckewaert, Thomas, Bessede, Alban, Ghiringhelli, François, Pulido, Marina, Italiano, Antoine
Publicado no JAMA Oncol (2017)

The cost-saving effect of centralized histological reviews with soft tissue and visceral sarcomas, GIST, and desmoid tumors: The experiences of the pathologists of the French Sarco...

Por Perrier, Lionel, Rascle, Pauline, Morelle, Magali, Toulmonde, Maud, Ranchere Vince, Dominique, Le Cesne, Axel, Terrier, Philippe, Neuville, Agnès, Meeus, Pierre, Farsi, Fadila, Ducimetière, Françoise, Blay, Jean-Yves, Ray Coquard, Isabelle, Coindre, Jean-Michel
Publicado no PLoS One (2018)

Brain Metastases and Place of Antiangiogenic Therapies in Alveolar Soft Part Sarcoma: A Retrospective Analysis of the French Sarcoma Group

Por Malouf, Gabriel G., Beinse, Guillaume, Adam, Julien, Mir, Olivier, Chamseddine, Ali N., Terrier, Philippe, Honore, Charles, Spano, Jean‐Philippe, Italiano, Antoine, Kurtz, Jean‐Emmanuel, Coindre, Jean‐Michel, Blay, Jean‐Yves, Le Cesne, Axel
Publicado no Oncologist (2019)

Options thérapeutiques de prise en charge des sarcomes durant la pandémie COVID-19 : propositions du groupe sarcome français

Por Penel, Nicolas, Bonvalot, Sylvie, Minard, Véronique, Orbach, Daniel, Gouin, François, Corradini, Nadège, Brahmi, Mehdi, Marec-Berard, Perrine, Briand, Sylvain, Gaspar, Nathalie, Llacer, Carmen, Carrere, Sébastien, Dufresne, Armelle, Le Cesne, Axel, Blay, Jean-Yves
Publicado no Bull Cancer (2020)

Frequent EGFR Positivity and Overexpression in High-Grade Areas of Human MPNSTs

Por Tabone-Eglinger, Séverine, Bahleda, Radislav, Côté, Jean-François, Terrier, Philippe, Vidaud, Dominique, Cayre, Anne, Beauchet, Alain, Théou-Anton, Nathalie, Terrier-Lacombe, Marie-José, Lemoine, Antoinette, Penault-Llorca, Frédérique, Le Cesne, Axel, Emile, Jean-François
Publicado em 2008